Navigation Links
New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS
Date:11/24/2009

WASHINGTON, Nov. 24 /PRNewswire-USNewswire/ -- America's pharmaceutical research and biotechnology companies are testing 97 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA). December 1 marks the 21st anniversary of "World AIDS Day" - a global awareness campaign that originated at the 1988 World Summit of Ministers of Health on Programmes for AIDS Prevention.

"We are greatly encouraged by these critically important medicines and vaccines in development to treat and prevent HIV infection," says PhRMA President and CEO Billy Tauzin. "Pharmaceutical researchers are continuing their efforts to develop new therapies and vaccines to improve and lengthen the lives of HIV-infected patients."

The report found that the 97 products in development include 23 vaccines and 54 antivirals. These drugs are either in human clinical trials or awaiting approval by the U.S. Food and Drug Administration.

Thirty-one medicines to treat HIV/AIDS have been approved since scientists first identified the virus that causes AIDS more than 20 years ago. The first HIV/AIDS medicine was approved in 1987, just four years after the virus was identified.

Although the U.S. Centers for Disease Control and Prevention (CDC) estimate that more than 1 million Americans were living with HIV infection at the end of 2006, the increased availability and utilization of newer prescription medicines has helped to reduce the U.S. death rate from AIDS substantially in recent years, according to government statistics. In fact, the CDC estimates that since the introduction of highly active anti-retroviral therapy in 1995, the annual number of deaths in the U.S. due to AIDS has dropped by more than 70 percent.

Despite this progress, AIDS remains a devastating and growing health problem in developing co
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase
2. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
3. Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015
4. Reportlinker Adds India Dental Devices Investment Opportunities, Analysis and Forecasts to 2015
5. Reportlinker Adds U.S. Market for PACS and EMR
6. Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective
7. Reportlinker Adds Holter Monitoring Systems - A Global Market Review
8. Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review
9. Reportlinker Adds Anesthesia Disposables - A World Market Review
10. Reported Use of AMAGs Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are On the Verge of Use
11. Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... AUSTIN, Texas , Oct. 31, 2014 /PRNewswire/ ... 3D holographic visualization technologies announced today a strategic ... industry leader in high-end 3D anatomy and biomedical ... the medical and medical education markets.  Zygote maintains ... anatomy and biomedical models and has pioneered development ...
(Date:10/31/2014)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP)( ... the development of oral drug delivery systems, announces ... to discuss the clinical results from its Phase ... oral insulin capsules, to treat type 1 diabetes ... Eastern time. Shareholders and other interested ...
(Date:10/31/2014)...  Zacks.com announces the list of stocks featured in the Analyst ... news and events impacting stocks and the financial markets. Stocks recently ... - Free Report ), Celgene (Nasdaq: CELG - ... Free Report ), Market Vectors Biotech ETF (AMEX: BBH ... XBI - Free Report ). Today, ...
Breaking Medicine Technology:Zebra Imaging and Zygote Media Partner to Bring 3D Visualization to the Medical Community 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 2The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 4The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 5The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 7
... May 3, 2012 Cardinal Health today reported a 3 ... and a 6 percent increase in non-GAAP operating earnings to ... in non-GAAP diluted earnings per share (EPS) from continuing operations ... solid quarter of revenue growth for both of our business ...
...  Cara Therapeutics, Inc. and Chong Kun Dang Pharmaceutical Corporation ... a licensing agreement that provides CKD Pharm with the ... drug candidate, CR845, in the Republic of Korea.  Under ... up-front payment, including an equity investment, and is eligible ...
Cached Medicine Technology:Cardinal Health Reports Third-Quarter Results 2Cardinal Health Reports Third-Quarter Results 3Cardinal Health Reports Third-Quarter Results 4Cardinal Health Reports Third-Quarter Results 5Cardinal Health Reports Third-Quarter Results 6Cardinal Health Reports Third-Quarter Results 7Cardinal Health Reports Third-Quarter Results 8Cardinal Health Reports Third-Quarter Results 9Cardinal Health Reports Third-Quarter Results 10Cardinal Health Reports Third-Quarter Results 11Cardinal Health Reports Third-Quarter Results 12Cardinal Health Reports Third-Quarter Results 13Cardinal Health Reports Third-Quarter Results 14Cardinal Health Reports Third-Quarter Results 15Cardinal Health Reports Third-Quarter Results 16Cardinal Health Reports Third-Quarter Results 17Cardinal Health Reports Third-Quarter Results 18Cardinal Health Reports Third-Quarter Results 19Cardinal Health Reports Third-Quarter Results 20Cardinal Health Reports Third-Quarter Results 21Cardinal Health Reports Third-Quarter Results 22Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market 2Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market 3
(Date:10/31/2014)... October 31, 2014 In an effort to ... Dr. Majid Jamali announced he will soon offer orthodontics at ... the end of November. , To build upon the ... of New York has become known for, Dr. Jamali is ... from such top learning institutions as UCLA, Stanford and UCSF. ...
(Date:10/31/2014)... October 31, 2014 Phoenix dentist , ... treatments for November. Whether patients simply need routine care or ... better time than now to get that necessary care. The ... put off routine and even essential treatments due to financial ... substantial savings on any treatments offered by the team at ...
(Date:10/31/2014)... 2014 Uniwigs.com newly arrived flip in ... model can comfortably attach itself around people’s heads with a ... generation of flip-in extensions comes with adjustable loops, which are ... part and customers can now adjust the wire to best ... people apply this new generation of flip ins, they simply ...
(Date:10/31/2014)... Med-Care Diabetic & Medical Supplies, Inc., a ... patient care and service, announced a new partnership with ... to provide an online Diabetes Health Center ... Health Center will provide topical information featuring news, physician ... Content will feature advice from leading medical experts and ...
(Date:10/31/2014)... simple steps can help make this weekend,s time change easier ... the end of Daylight Saving Time in the fall is ... spring. The main reason is because we gain an hour ... director of the Center for Sleep Medicine at Northern Westchester ... release. The many Americans who are sleep-deprived should go ...
Breaking Medicine News(10 mins):Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 2Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 3Health News:Phoenix Dentist, Dr. Christy, is Now Offering Ten Percent Off On All Dental Treatments for the Month of November 2Health News:UniWigs Unveiles New Generation of Flip In Hair Extensions 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 3Health News:Make the Most of This Weekend's Time Change 2
... people who are unlikely to incur high medical expenses. ... families, finds a study of Massachusetts families from Children,s ... Care and Prevention (DACP). The study appears in the ... The researchers, led by Alison Galbraith, MD, MPH, and ...
... survive severe injuries on battlefields such as those in ... infections of their wounds with multidrug resistant bacteria. The ... Staphylococcus aureus (MRSA), Acinetobacter baumannii , ... coli . , Dr Clinton K. Murray, from Brooke ...
... to create open access to information that will enhance ... ORLANDO, Fla., March 29 /PRNewswire/ -- ... GE Healthcare,s Cardiovascular Ultrasound unit announced a formal affiliation ... an integrated solution aimed at improving workflow for echocardiography ...
... allergen breathed in by a person with asthma triggers a ... events to prompt an allergic reaction, said a consortium of ... in Houston in a report that appears online today in ... activates interleukin 25, a key mediator of the allergic response ...
... Relaxin cuts shortness of breath and trimmed hospital stays, phase ... The hormone relaxin reduces shortness of breath and cardiovascular death ... pressure, according to a phase 2 trial conducted in eight ... a few hours of arriving at a hospital, were randomly ...
... Doctor urges first responders to clean equipment regularly ... News) -- One in three stethoscopes used by ... methicillin-resistant Staphylococcus aureus (MRSA) bacteria, a new study ... and Dentistry of New Jersey swabbed 50 stethoscopes ...
Cached Medicine News:Health News:Low-income families with sick children often enrolled in high-deductible health care plans 2Health News:ProSolv CardioVascular and GE Healthcare Ultrasound Division Announce Affiliation 2Health News:ProSolv CardioVascular and GE Healthcare Ultrasound Division Announce Affiliation 3Health News:Hormone Reduces Mortality in Heart Patients With High BP 2Health News:Third of EMS Stethoscopes Carry MRSA Bacterium 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: